109 related articles for article (PubMed ID: 12761353)
1. Local anesthetic block of Kv channels: role of the S6 helix and the S5-S6 linker for bupivacaine action.
Nilsson J; Madeja M; Arhem P
Mol Pharmacol; 2003 Jun; 63(6):1417-29. PubMed ID: 12761353
[TBL] [Abstract][Full Text] [Related]
2. Kvbeta1.3 reduces the degree of stereoselective bupivacaine block of Kv1.5 channels.
Arias C; Guizy M; David M; Marzian S; González T; Decher N; Valenzuela C
Anesthesiology; 2007 Oct; 107(4):641-51. PubMed ID: 17893461
[TBL] [Abstract][Full Text] [Related]
3. A single residue in the S6 transmembrane domain governs the differential flecainide sensitivity of voltage-gated potassium channels.
Herrera D; Mamarbachi A; Simoes M; Parent L; Sauvé R; Wang Z; Nattel S
Mol Pharmacol; 2005 Aug; 68(2):305-16. PubMed ID: 15883204
[TBL] [Abstract][Full Text] [Related]
4. Point mutations at L1280 in Nav1.4 channel D3-S6 modulate binding affinity and stereoselectivity of bupivacaine enantiomers.
Nau C; Wang SY; Wang GK
Mol Pharmacol; 2003 Jun; 63(6):1398-406. PubMed ID: 12761351
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the outer pore region of the apamin-sensitive Ca2+-activated K+ channel rSK2.
Jäger H; Grissmer S
Toxicon; 2004 Jun; 43(8):951-60. PubMed ID: 15208028
[TBL] [Abstract][Full Text] [Related]
6. Molecular site of action of the antiarrhythmic drug propafenone at the voltage-operated potassium channel Kv2.1.
Madeja M; Leicher T; Friederich P; Punke MA; Haverkamp W; Musshoff U; Breithardt G; Speckmann EJ
Mol Pharmacol; 2003 Mar; 63(3):547-56. PubMed ID: 12606761
[TBL] [Abstract][Full Text] [Related]
7. Amide local anesthetics potently inhibit the human tandem pore domain background K+ channel TASK-2 (KCNK5).
Kindler CH; Paul M; Zou H; Liu C; Winegar BD; Gray AT; Yost CS
J Pharmacol Exp Ther; 2003 Jul; 306(1):84-92. PubMed ID: 12660311
[TBL] [Abstract][Full Text] [Related]
8. The 'functional' dyad of scorpion toxin Pi1 is not itself a prerequisite for toxin binding to the voltage-gated Kv1.2 potassium channels.
Mouhat S; Mosbah A; Visan V; Wulff H; Delepierre M; Darbon H; Grissmer S; De Waard M; Sabatier JM
Biochem J; 2004 Jan; 377(Pt 1):25-36. PubMed ID: 12962541
[TBL] [Abstract][Full Text] [Related]
9. Molecular determinants of KCNQ1 channel block by a benzodiazepine.
Seebohm G; Chen J; Strutz N; Culberson C; Lerche C; Sanguinetti MC
Mol Pharmacol; 2003 Jul; 64(1):70-7. PubMed ID: 12815162
[TBL] [Abstract][Full Text] [Related]
10. Molecular determinants of stereoselective bupivacaine block of hKv1.5 channels.
Franqueza L; Longobardo M; Vicente J; Delpón E; Tamkun MM; Tamargo J; Snyders DJ; Valenzuela C
Circ Res; 1997 Dec; 81(6):1053-64. PubMed ID: 9400387
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of S6 mutations on binding of quinidine and 4-aminopyridine to rat isoform of Kv1.4: common site but different factors in determining blockers' binding affinity.
Zhang H; Zhu B; Yao JA; Tseng GN
J Pharmacol Exp Ther; 1998 Oct; 287(1):332-43. PubMed ID: 9765354
[TBL] [Abstract][Full Text] [Related]
12. Novel alpha-KTx sites in the BK channel and comparative sequence analysis reveal distinguishing features of the BK and KV channel outer pore.
Giangiacomo KM; Becker J; Garsky C; Schmalhofer W; Garcia ML; Mullmann TJ
Cell Biochem Biophys; 2008; 52(1):47-58. PubMed ID: 18815746
[TBL] [Abstract][Full Text] [Related]
13. Conformational dynamics of the inner pore helix of voltage-gated potassium channels.
Choe S; Grabe M
J Chem Phys; 2009 Jun; 130(21):215103. PubMed ID: 19508102
[TBL] [Abstract][Full Text] [Related]
14. The molecular basis of high-affinity binding of the antiarrhythmic compound vernakalant (RSD1235) to Kv1.5 channels.
Eldstrom J; Wang Z; Xu H; Pourrier M; Ezrin A; Gibson K; Fedida D
Mol Pharmacol; 2007 Dec; 72(6):1522-34. PubMed ID: 17872968
[TBL] [Abstract][Full Text] [Related]
15. Lipophilic and stereospecific interactions of amino-amide local anesthetics with human Kv1.1 channels.
Punke MA; Friederich P
Anesthesiology; 2008 Nov; 109(5):895-904. PubMed ID: 18946303
[TBL] [Abstract][Full Text] [Related]
16. Identification of amino acid residues involved in dendrotoxin block of rat voltage-dependent potassium channels.
Hurst RS; Busch AE; Kavanaugh MP; Osborne PB; North RA; Adelman JP
Mol Pharmacol; 1991 Oct; 40(4):572-6. PubMed ID: 1921987
[TBL] [Abstract][Full Text] [Related]
17. A set of homology models of pore loop domain of six eukaryotic voltage-gated potassium channels Kv1.1-Kv1.6.
Liu HL; Lin JC
Proteins; 2004 May; 55(3):558-67. PubMed ID: 15103620
[TBL] [Abstract][Full Text] [Related]
18. Influence of non-P region domains on selectivity filter properties in voltage-gated K+ channels.
Immke D; Kiss L; LoTurco J; Korn SJ
Recept Channels; 1998; 6(3):179-88. PubMed ID: 10100326
[TBL] [Abstract][Full Text] [Related]
19. Altered gating and local anesthetic block mediated by residues in the I-S6 and II-S6 transmembrane segments of voltage-dependent Na+ channels.
Kondratiev A; Tomaselli GF
Mol Pharmacol; 2003 Sep; 64(3):741-52. PubMed ID: 12920212
[TBL] [Abstract][Full Text] [Related]
20. The P-region and S6 of Kv3.1 contribute to the formation of the ion conduction pathway.
Aiyar J; Nguyen AN; Chandy KG; Grissmer S
Biophys J; 1994 Dec; 67(6):2261-4. PubMed ID: 7696467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
